Involvement of the glutathione S-conjugate compounds and the MRP protein in Tc-99m-tetrofosmin and Tc-99m-sestamibi uptake in glioma cell lines

Nuclear Medicine and Biology

Volumn 27, Issue 3, 2000, Pages 299-307

  Perek, Nathalie ^a   Prevot, Nathalie ^a   Koumanov, Françoise ^a   Frere, Delphine ^a   Sabido, Odile ^b   Beauchesne, Patrick ^c   Dubois, Francis ^a  

^a Dept of Biophys and Image Treatm   (France)

^b UNIVERSITÉ JEAN MONNET   (France)

^c SERVICE DE NEUROLOGIE   (France)

Author keywords

Glioma cell lines; GS X MRP pump; Multidrug resistance; Radiopharmaceuticals; Tc 99m tetrofosmin; Tc 99m sestamibi

Indexed keywords

GLUTATHIONE TRANSFERASE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; MULTIDRUG RESISTANCE PROTEIN; TETROFOSMIN TC 99M;

ARTICLE; ASTROCYTOMA; BIOACCUMULATION; CANCER RESISTANCE; CONTROLLED STUDY; DISEASE MARKER; DRUG UPTAKE; GLIOBLASTOMA; GLIOMA CELL; HUMAN; HUMAN CELL; MULTIDRUG RESISTANCE;

ANTIBODIES, MONOCLONAL; ATP-BINDING CASSETTE TRANSPORTERS; BRAIN NEOPLASMS; FLOW CYTOMETRY; GENES, MDR; GLIOMA; GLUTATHIONE; HUMANS; IMMUNOGLOBULIN G; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; ORGANOPHOSPHORUS COMPOUNDS; ORGANOTECHNETIUM COMPOUNDS; RADIOPHARMACEUTICALS; TECHNETIUM TC 99M SESTAMIBI; TUMOR MARKERS, BIOLOGICAL;

EID: 0034025598     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-8051(00)00085-8     Document Type: Article

References (45)

1. Abe T., Hasegawa S., Taniguchi K., Yokomizo A., Kuwano T., Ono M., Mori T., Hori S., Kohno K., Kuwano M. Possible involvement of multidrug resistant associated protein MRP gene expression in spontaneous drug resistance to vincristine, etoposide and adriamycin in human glioma cells. Int. J. Cancer. 58:1994;860-864.
2. Abe T., Mori T., Wakabayashi Y., Nakagawa M., Cole S.P., Koike K., Kuwano M., Hori S. Expression of multidrug resistance protein gene in patients with glioma after chemotherapy. J. Neurooncol. 40:1998;11-18.
3. Andrews D.W., Das R., Kim S., Zhang J., Curtis M. Technetium-MIBI as a glioma imaging agent for the assessment of multi-drug resistance. Neurosurgery. 40:1997;1323-1332.
4. Arbab A.S., Koizumi K., Toyama K., Araki T. Uptake of technetium-99m-tetrofosmin, technetium-99m-MIBI and thallium-201 in tumor cell lines. J. Nucl. Med. 37:1996;1551-1556.
5. 201Tl in a tumour cell line. Nucl. Med. Commun. 18:1997;235-240.
6. Arceci R.J., Stieglitz K., Bras J., Schinkel A., Baas F., Croop J. Monoclonal antibody to an external epitope of the human mdr1 P-glycoprotein. Cancer Res. 53:1993;310-317.
7. Armond S.J., Eng L.F., Rubinstein J. The application of glial fibrillary acid protein immunohistochemistry in neuro oncology. Path. Res. Pract. 168:1980;374-394.
8. Ballinger J.R., Bannerman J., Boxen I., Firby P., Hartman N.G., Moore M.J. Technetium-99m-tetrofosmin as a substrate for P-glycoprotein In vitro studies in multidrug-resistant breast tumor cells . J. Nucl. Med. 37:1996;1578-1582.
9. Beauchesne P., Bertrand S., N'guyen M.J., Christianson T., Dore J.F., Mornex F., Bonner J.A. Etoposide sensitivity of radioresistant human glioma cell lines. Cancer Chemother. Pharmacol. 41:1998;93-97.
10. Beauchesne P., Soler C., Maatougui K., Schmitt T., Barral F.G., Michel D., Dubois F., Brunon J. Interest of Tc-99-sestamibi SPECT for detection of recurrent gliomas after treatment failure. Cancer Radiother. 2:1998;42-48.
11. Carvalho P.A., Chiu M.L., Kronauge J.F., Kawamura M., Jones A.G., Holman B.L., Piwnica-Worms D. Subcellular distribution and analysis of technetium-99m-mibi in isolated perfused rat hearts. J. Nucl. Med. 33:1992;1516-1522.
12. Chiu M.L., Kronauge J.F., Piwnica-Worms D. Effect of mitochondrial and plasma membrane potentials on accumulation of hexakis (2-methoxyisobutylisonitrile) technetium(I) in cultured mouse fibroblasts. J. Nucl. Med. 31:1990;1646-1653.
13. Cole S.P., Bhardwaj G., Gerlach J.H., Mackie J.E., Grant C.E., Almquist K.C., Stewart A.J., Kurz E.U., Duncan A.M., Deeley R.G. Overexpression of a transport gene in multidrug resistant human lung cancer cell line. Science. 258:1992;1650-1654.
14. Cordon-Cardo C., O'Brien J.P., Casals D., Rittman-Grauer L., Biedler J.L., Melamed M.R., Bertino J.R. Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood brain barrier sites. Proc. Natl. Acad. Sci. USA. 86:1989;695-698.
15. Duran-Cordobes M., Starzec A., Delmon-Moigeon L., Blanchot C., Kouyoumdjian J.-C., Prevost G., Caglar M., Moretti J.-L. Technetium-99m-sestamibi uptake by human benign and malignant brest tumor cells Correlation with mdr gene expression . J. Nucl. Med. 37:1996;286-289.
16. Feller N., Broxterman H.J., Wahrer D.C.R., Pinedo H.M. ATP dependent efflux on calcein by the multidrug resistance protein (MRP) No inhibition by intracellular glutathione depletion . FEBS Lett. 368:1995;385-388.
17. Ferrand V.L., Montero Julian F.A., Chauvet M.M., Hirn M.H., Bourdeaux M.J. Quantitative determination of the MDR-related P glycoprotein Pgp 170, by a rapid flow cytometric technique. Cytometry. 23:1996;120-125.
18. Flens M.J., Izquierdo M.A., Scheffer G.L., Fritz J.M., Meijer C.J., Scheper R.J., Zaman G.J. Immunochemical detection of the multidrug resistance-associated protein MRP in human multidrug-resistant tumor cells by monoclonal antibodies. Cancer Res. 54:1994;4557-4563.
19. Gottesman M., Pastan I. The multidrug transporter, a double-edge sword. J. Biol. Chem. 263:1988;12163-12166.
20. Hendrikse N.H., Franssen E.J., van der Graaf W.T., Meijer C., Piers D.A., Vaalburg W., de Vries E.G. Tc-99m-sestamibi is a substrate for P-glycoprotein and the multidrug resistance-associated protein. Br. J. Cancer. 77:1998;353-358.
21. Hipfner D.R., Gao M., Scheffer G., Scheper R.J., Deeley R.G., Cole S.P. Epitope mapping of monoclonal antibodies specific for the 190 kDa multidrug resistance protein (MRP). Br. J. Cancer. 78:1998;1134-1140.
22. Hösli P., Sappino A.P., de Tribolet N., Dietrich P.Y. Malignant glioma Should chemotherapy be overthrown by experimental treatments? Ann. Oncol. 9:1998;589-600.
23. Jedlitschky G., Leier I., Buchholz U., Center M., Keppler D. ATP-dependent transport of glutathione S-conjugates by the multidrug resistance-associated protein. Cancer Res. 54:1994;4833-4836.
24. Kabasakal L., Ozker K., Hayward M., Akansel G., Griffith O., Hellman R., Collier D. Technetium-99m sestamibi uptake in human breast carcinoma cell lines displaying glutathione associated drug-resistance. Eur. J. Nucl. Med. 23:1996;568-570.
25. Kantor R.R., Giardina S.L., Bartolazzi A., Townsend A.J., Myers C.E., Cowan K.H., Longo D.L., Natali P.G. Monoclonal antibodies to glutathione S-transferase pi-immunohistochemical analysis of human tissues and cancers. Int. J. Cancer. 47:1991;193-201.
26. Khalkhali I., Mena I., Diggles L. Review of imaging techniques for the diagnosis of breast cancer A new role of prone scintimammography using technetium-99m sestamibi . Eur. J. Nucl. Med. 21:1994;357-362.
27. Mansi L., Rambaldi P.F., Procaccini E., Gregorio F.D., Laprovitera A., Pecori B., Vecchio W.D. Scintimammography with technetium-99m tetrofosmin in the diagnosis of breast cancer and lymph node metastases. Eur. J. Nucl. Med. 23:1996;932-939.
28. Meister A. Glutathione, ascorbate and cellular protection. Cancer Res. 54:1994;1969S-1975S.
29. Moretti J.L., Caglar M., Duran Cordobes M., Morere J.F. Can nuclear medicine predict response to chemotherapy? Eur. J. Nucl. Med. 22:1995;97-100.
30. Moretti J.L., Duran Cordobes M., Starzec A., de Beco V., Vergote J., Benazzouz F., Boissier B., Cohen H., Safi N., Piperno-Neumann S., Kouyoumdjian J.C. Involvement of glutathione in loss of technetium-99m-MIBI accumulation related to membrane MDR protein expression in tumor cells. J. Nucl. Med. 39:1998;1214-1218.
31. Mousseau M., Chauvin C., Nissou M.F., Chaffanet M., Plantaz D., Pasquier B., Schaerer R., Benabid A. A study of four chemoresistance-related genes in human primary and metastatic brain tumours. Eur. J. Cancer. 5:1993;759-762.
32. Muller M., Meijer C., Zaman G.J., Borst P., Scheper R.J., Mulder N.H., de Vries E.G., Jansen P.L. Overexpression of the gene encoding the multidrug resistance-associated protein results in increased ATP-dependent glutathione S-conjugate transport. Proc. Natl. Acad. Sci. USA. 20:1994;13033-13037.
33. Park C.H., Kim S.M., Zhang J.J., Intenzo C.M., McEwan J.R. Tc-99m-sestamibi brain SPECT in the diagnosis of recurrent glioma. Clin. Nucl. Med. 19:1994;57-58.
34. Piwnica-Worms D., Chiu M.L., Budding M., Kronauge J.F., Kramer R.A., Croop J.M. Functional imaging of multidrug resistant P-glycoprotein with an organotechnetium complex. Cancer Res. 53:1993;977-984.
35. Piwnica-Worms D., Kronauge J.F., Chiu M.L. Uptake and retention of hexakis (2-methoxyisobutyl isonitrile) technetium(I) in cultured chick myocardial cells. Mitochondrial and plasma membrane potential dependence. Circulation. 82:1990;1826-1838.
36. Platts E.A., North T.L., Pickett R.D., Kelly J.D. Mechanism of uptake of technetium tetrofosmin. Uptake into isolated adult rat ventricular myocytes and subcellular localisation. J. Nucl. Cardiol. 2:1995;317-326.
37. Poncelet P., George F., Papa S., Lanza F. Cytofluorometric quantification of cell-surface antigens by indirect immunofluorescence using monoclonal antibodies. J. Immunol. Methods. 85:1985;65-74.
38. Van Luyn M.J., Muller M., Renes J., Meijer C., Scheper R.J., Nienhuis E.F., Mulder N.H., Jansen P.L., De Vries E.G. Transport of glutathione conjugates into secretory vesicles is mediated by the multidrug-resistance protein 1. Int. J. Cancer. 76:1998;55-62.
39. Verovski V.N., Van den Berge D.L., Delvaeye M.M., Scheper R.J., De Neve W.J., Storme G.A. Low level doxorubicin resistance in P-glycoprotein negative human pancreatic tumour PSN1/ADR cells implicates in brefeldin A sensitive mechanism of drug extrusion. Br. J. Cancer. 73:1996;596-602.
40. Versantvoort C.H., Bagrij T., Wright K.A., Twentyman P.R. On the relationship between the probenecid-sensitive transport of daunorubicin or calcein and the glutathione status of cells overexpressing the multidrug resistance-associated protein (MRP). Int. J. Cancer. 63:1995;855-862.
41. Versantvoort C.H., Broxterman H.J., Lankelma J., Feller N., Pinedo H.M. Competitive inhibition by genistein and ATP dependence of daunorubicin transport in intact MRP overexpressing human small cell lung cancer cells. Biochem. Pharmacol. 48:1994;1129-1136.
42. Versantvoort C.H.M., Schuurhuis G.J., Pinedo H.M., Eekman C.A., Kuiper C., Lankelma J., Broxterman H.J. Genistein modulates the decreased drug accumulation in non-P-glycoprotein mediated multidrug resistant tumour cells. Br. J. Cancer. 68:1993;939-946.
43. Vichi P.J., Tritton T.R. Protection from adriamycin cytotoxicity in L1210 cells by Brefeldin A. Cancer Res. 53:1993;5237-5243.
44. Zaman G.J., Flens M.J., van Leusden M.R., de Haas M., Mulder H.S., Lankelma J., Pinedo H.M., Scheper R.J., Baas F., Broxterman H.J., Borst P. The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump. Proc. Natl. Acad. Sci. USA. 91:1994;8822-8826.
45. Zaman G.J., Lankelma J., van Tellingen O., Beijnen J., Dekker H., Paulusma C., Elferink R.P.J.O., Baas F., Borst P. Role of glutathione in the export of compounds from cells by the multidrug-resistance-associated protein. Proc. Natl. Acad. Sci. USA. 92:1995;7690-7694.